Touzeau, C., Perrot, A., Roussel, M., Karlin, L., Benboubker, L., Jacquet, C., Mohty, M., Facon, T., Manier, S., Chretien, M.-L., Tiab, M., Hulin, C., Leleu, X., Loiseau, H. A., Dejoie, T., Planche, L., Attal, M. and Moreau, P. (2022) “All-oral triplet combination of ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible multiple myeloma patients: final results of the phase II IFM 2013-06 study”, Haematologica. Pavia, Italy, 107(7), pp. 1693-1697. doi: 10.3324/haematol.2021.280394.